FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to otolaryngology, neurology and immunology, and can be used for treatment/rehabilitation of patients with chronic post-viral olfactory disorders.
EFFECT: what is presented is the use of a conditioned medium of type 2 macrophage cultures for recovery of olfactory function in patients with chronic post-viral olfactory disorders by intranasal administration.
1 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHYSICAL THERAPY OF ANOSMIA AFTER CORONAVIRUS INFECTION | 2021 |
|
RU2751823C1 |
METHOD FOR ASSESSING THE THRESHOLD OF OLFACTION IN CHILDREN | 2021 |
|
RU2770290C1 |
USE OF PEPTIDE OF FORMULA MET-GLU-HIS-PHE-PRO-GLY-PRO FOR TREATING ANOSMIA IN COVID-19 | 2023 |
|
RU2816583C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
METHOD FOR REHABILITATION OF PATIENTS WITH OLFACTORY DISORDERS | 2022 |
|
RU2806234C1 |
METHOD OF TREATING PATIENTS WITH OLFACTORY DYSFUNCTION IN ATROPHIC RHINITIS | 2019 |
|
RU2713786C1 |
METHOD FOR TREATING DYSOSMIA CAUSED BY CORONAVIRUS INFECTION | 2021 |
|
RU2791808C2 |
METHOD FOR EARLY DETECTION OF NEUROLOGICAL DISORDERS IN PATIENTS WITH COVID-19 | 2021 |
|
RU2779562C1 |
METHOD FOR INDIVIDUAL CLINICAL AND PSYCHOLOGICAL REHABILITATION OF PATIENTS WITH POST-COVID SYNDROME | 2022 |
|
RU2783330C1 |
SYSTEM AND METHOD FOR REHABILITATION (RESTORATION) OF THE SENSE OF SMELL AND TASTE, AS WELL AS CORRECTION OF EMOTIONAL AND COGNITIVE DISORDERS USING THE BRAIN-COMPUTER INTERFACE | 2021 |
|
RU2768172C1 |
Authors
Dates
2024-03-28—Published
2023-06-30—Filed